PHARMATECA » №s3-16 / 2016

N.V. Toroptsova (1), I.A. Baranova (2), O.M. Lesnyak (3, 4) RECOMMENDATIONS FOR USE OF THE RUSSIAN MODEL FRAX® FOR DETERMINING 10-YEAR PROBABILITY OF OSTEOPOROTIC FRACTURES	10-14
N.Yu. Karpova (1), M.A.Rashid (2), T.V. Kazakova (1), M.E. Yadrov (2) CALCIUM METABOLISM AND BONE HOMEOSTASIS	16-21
C. Speed, B. Wohlfarth CURRENT APPROACHES TO THERAPY OF PAIN SYNDROME IN SOFT TISSUE INJURIES	22-29
E.G .Zotkin HEEL PREPARATIONS IN THE COMPLEX THERAPY OF OSTEOARTHROSIS	30-34
S.S. Rodionova, U.R. Khakimov RATIONALE FOR USE OF ALFACALCIDOL IN COMBINATION WITH BISPHOSPHONATES IN POSTMENOPAUSAL AND SENILE FORMS OF SYSTEMIC OSTEOPOROSIS	35-40
T.V. Beketova REGISTER OF PATIENTS WITH SYSTEMIC ANCA-ASSOCIATED VASCULITIDES AS INNOVATIVE TOOL OF PERSONALIZED THERAPY	41-49
O.V. Dobrovolskaya, N.V. Demin, N.V. Toroptsova FOREARM BONE MINERAL DENSITY AS A PREDICTOR OF AXIAL OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH PRIOR LOW-ENERGY BONE FRACTURES	50-55